References

Alfano D., Franco P., Vocca I., Gambi N., Pisa V., Mancini A., Caputi M., Carriero M.V., Iaccarino I. & Stoppelli M.P. 2005. The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis. Thromb. Haemost. 93: 205–211.10.1160/TH04-09-0592Search in Google Scholar PubMed

Balsara R.D. & Ploplis V.A. 2008. Plasminogen activator inhibitor-1: the double-edged sword in apoptosis. Thromb. Haemost. 100: 1029–1036.10.1160/TH08-07-0427Search in Google Scholar

Barazzone C., Belin D., Piguet PF., Vassalli J.D. & Sappino A.P. 1996. Plasminogen activator inhibitor1 in acute hyperoxic mouse lung injury. J. Clin. Invest. 98: 2666–2673.10.1172/JCI119089Search in Google Scholar PubMed PubMed Central

Bertozzi P., Astedt B., Zenzius L., Lynch K., LeMaire F., Zapol W. & Chapman H.A Jr. 1990. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N. Engl. J. Med. 322: 890–897.10.1056/NEJM199003293221304Search in Google Scholar PubMed

Bhandary Y.P., Shetty S.K., Marudamuthu A.S., Gyetko M.R., Idell S., Kermani M.G., Shetty R.S., Starcher B.C. & Shetty S. 2012. Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system. Am. J. Physiol. Lung Cell. Mol. Physiol. 302: L463–L473.10.1152/ajplung.00099.2011Search in Google Scholar PubMed PubMed Central

Bhandary Y.P., Shetty S.K., Marudamuthu A.S., Ji H.L., Neuenschwander P.F., Boggaram V., Morris G.F., Fu J., Idell S. & Shetty S. 2013. Regulation of alveolar epithelial injury and lung fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1. Am. J. Path. 183: 131–143.10.1016/j.ajpath.2013.03.022Search in Google Scholar PubMed PubMed Central

Bhandary Y.P., Shetty S.K., Marudamuthu A.S., Fu J., Pinson B.M., Levin J. & Shetty S. 2015a. Role of p53-fibrinolytic system cross-talk in the regulation of quartz-induced lung injury. Toxicol. Appl. Pharmacol. 283: 92–98.10.1016/j.taap.2015.01.007Search in Google Scholar PubMed

Bhandary Y.P., Shetty S.K., Marudamuthu A.S., Midde K.K., Ji H.L., Shams H., Idell S., Fu J. & Shetty S. 2015b. Plasminogen activator inhibitor-1 in cigarette smoke exposure and influenza A virus infection-induced lung injury. Plos One 10: e0123187.10.1371/journal.pone.0123187Search in Google Scholar PubMed PubMed Central

Drapkin P.T., O’Riordan C.R., Yi S.M., Chiorini J.A., Cardella J., Zabner J. & Welsh M.J. 2000. Targeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelia. J. Clin. Invest. 105: 589–596.10.1172/JCI8858Search in Google Scholar PubMed PubMed Central

Eitzman D.T., McCoy R.D., Zheng X., Fay W.P., Shen T., Ginsburg D. & Simon R.H. 1996. Bleomycin induced pulmonary fibrosis in transgenic mice that either lack or over express the murine plasminogen activator inhibitor1 gene. J. Clin. Invest. 97: 232–237.10.1172/JCI118396Search in Google Scholar PubMed PubMed Central

Haraquchi M. 2009. The role of the transcriptional regulator snail in cell detachment, reattachment and migration. Cell. Adh. Migr. 3: 259–263.10.4161/cam.3.3.8259Search in Google Scholar

Horowitz J.C., Rogers D.S., Simon R.H., Sisson T.H. & Thannickal V.J. 2008. Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis. Am. J. Respir. Cell. Mol. Biol. 38: 78–87.10.1165/rcmb.2007-0174OCSearch in Google Scholar

Hua F., Ren W. & Zhu L. 2011. Plasminogen activator inhibitor type-1 deficiency exaggerates LPS-induced acute lung injury through enhancing Toll-like receptor 4 signaling pathway. Blood Coagul. Fibrinolysis 22: 480–486.10.1097/MBC.0b013e328346ef56Search in Google Scholar

Idell S. 1994. Extravascular coagulation and fibrin deposition in acute lung injury. New Horiz. 2: 566–574.Search in Google Scholar

Idell S. 1995. Coagulation, fibrinolysis and fibrin deposition in lung injury and repair, pp. 743–776. In: Phan S.H. & Thrall R.S. (eds) Pulmonary Fibrosis. New York, Dekker.Search in Google Scholar

Idell S. 2002. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways. Crit. Care Med. 30: S274–S280.10.1097/00003246-200205001-00017Search in Google Scholar

Idell S. 2003. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit. Care Med. 31: S213–S220.10.1097/01.CCM.0000057846.21303.ABSearch in Google Scholar

Jeffery P.K. 2001. Remodeling in asthma and chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 164: S28–S38.10.1164/ajrccm.164.supplement_2.2106061Search in Google Scholar

Lisanti M.P., Tang Z., Scherer P.E., Kubler E., Koleske A.J. & Sargiacomo M. 1995. Caveolae, transmembrane signalling and cellular transformation. Mol. Membr. Biol. 12: 121–124.10.3109/09687689509038506Search in Google Scholar

Liu J., Lee P., Galbiati F., Kitsis R.N. & Lisanti M.P. 2001. Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation. Am. J. Physiol. Cell. Physiol. 280: C823–C835.10.1152/ajpcell.2001.280.4.C823Search in Google Scholar

Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., Hoffman B. & Reed J.C. 1994. Tumor suppressor P53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene9: 1799–1805.Search in Google Scholar

Miyashita T. & Reed J.C. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293–299.10.1016/0092-8674(95)90412-3Search in Google Scholar

Olman M.A., Mackman N., Gladson C.L., Moser K.M. & Loskutoff D.J. 1995. Changes in procoagulant and fibrinolytic gene expression during bleomycin induced lung injury in the mouse. J. Clin. Invest. 96: 1621–1630.10.1172/JCI118201Search in Google Scholar PubMed PubMed Central

Park Y.J., Liu G., Lorne E.F., Zhao X. & Wang J. 2008. PAI-1 inhibits neutrophil efferocytosis. Proc. Natl. Acad. Sci. USA 105: 11784–11789.10.1073/pnas.0801394105Search in Google Scholar PubMed PubMed Central

Sapru A., Curley M.A., Brady S., Matthay M.A. & Flori H. 2010. Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury. Intensive Care Med. 36: 157–163.10.1007/s00134-009-1690-2Search in Google Scholar PubMed PubMed Central

Serrano-Mollar A., Nacher M., Gay-Jordi G., Closa D., Xaubet A. & Bulbena O. 2007. Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis. Am. J. Respir. Crit. Care Med. 176: 1261–1268.10.1164/rccm.200610-1491OCSearch in Google Scholar PubMed

Shetty P., Velusamy T., Bhandary Y P., Liu M., Shetty R.S. & Shetty S. 2008. Urokinase expression by tumor suppressor protein p53: a novel role in mRNA turnover. Am. J. Resp. Cell. Mol. Biol. 39: 364–372.10.1165/rcmb.2007-0406OCSearch in Google Scholar PubMed PubMed Central

Shetty S.K., Bhandary Y.P., Marudamuthu A.S., Abernathy D., Veluswamy T., Starcher B. & Shetty S. 2012. Regulation of airway and alveolar epithelial cell apoptosis by p53 induced PAI-1 during cigarette smoke exposure injury. Am. J. Respir. Cell. Mol. Biol. 47: 474–483.10.1165/rcmb.2011-0390OCSearch in Google Scholar PubMed PubMed Central

Shetty S., Gyetko M.R. & Mazar A.P. 2005. Induction of p53 by urokinase in lung epithelial cells. J. Biol. Chem. 280: 28133– 28141.10.1074/jbc.M413190200Search in Google Scholar PubMed

Shetty S. & Idell S. 2000. Post-transcriptional regulation of urokinase mRNA. Identification of a novel urokinase mRNA-binding protein in human lung epithelial cells in vitro. J. Biol. Chem. 275: 13771–13779.10.1074/jbc.275.18.13771Search in Google Scholar PubMed

Shetty S., John J. & Idell S. 2007a. Fibrosis including fibrinolytic pathways, pp. 101–103. In: Light R.W. & Lee Y.C.G. (eds) Textbook of Pleural Diseases, 2^nd Edition. London: Hodder Arnold.Search in Google Scholar

Shetty S., Padijnayayveetil J., Tucker T., Stankowska D. & Idell S. 2008a. The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L967–L975.10.1152/ajplung.90349.2008Search in Google Scholar PubMed

Shetty S., Rao G.N., Cines D.B. & Bdeir K. 2006. Urokinase induces activation of STAT3 in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L772–L780.10.1152/ajplung.00476.2005Search in Google Scholar PubMed

Shetty S., Shetty P., Velusamy T., Idell S., Bhandary Y.P. & Shetty R.S. 2008b. Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53. J. Biol. Chem. 283: 19570–19580.10.1074/jbc.M710268200Search in Google Scholar PubMed PubMed Central

Shetty S., Velusamy T., Shetty P., Idell S., Mazar A.P., Bhandary Y.P. & Shetty R.S. 2007b. Regulation of urokinase receptor expression by p53: a novel role in stabilization of uPAR mRNA. Mol. Cell. Biol. 27: 5607–5618.10.1128/MCB.00080-07Search in Google Scholar PubMed PubMed Central

Simpson A.J., Gray R.S., Moore N.R. & Booth NA. 1997. The effects of chronic smoking on the fibrinolytic potential of plasma and platelets. Br. J. Haematol. 97: 208–213.10.1046/j.1365-2141.1997.d01-2137.xSearch in Google Scholar PubMed

Sisson T.H., Hattori N., Xu Y. & Simon R.H. 1999. Treatment of bleomycin induced pulmonary fibrosis by transfer of urokinase type plasminogen activator genes. Hum. Gene Ther. 10: 2315–2323.10.1089/10430349950016960Search in Google Scholar PubMed

Tiddens H., Silverman M. & Bush A. 2000. The role of inflammation in airway disease: remodeling. Am. J. Respir. Crit. Care Med. 162: S7–S10.10.1164/ajrccm.162.supplement_1.maic-2Search in Google Scholar PubMed

Wanaski S.P., Ng B.K. & Glaser M. 2003. Caveolin scaffolding region and the membrane binding region of SRC form lateral membrane domains. Biochemistry 42: 42–56.10.1021/bi012097nSearch in Google Scholar PubMed

Wei Y., Yang X., Liu Q., Wilkins J.A. & Chapman H.A. 1999. A role of caveolin and the urokinase receptor in integrinmediated adhesion and signaling. J. Cell. Biol. 144: 1285–1294.10.1083/jcb.144.6.1285Search in Google Scholar PubMed PubMed Central